Friess Associates LLC Regeneron Pharmaceuticals, Inc. Transaction History

Friess Associates LLC

  • $59.9 Million
  • Q2 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 15, 2019
SELL
$372.08 - $439.57 $15.3 Million - $18.1 Million
-41,200 Closed
0 $0
Q4 2018

Feb 14, 2019
SELL
$335.82 - $403.04 $2.8 Million - $3.37 Million
-8,350 Reduced 16.85%
41,200 $15.4 Million
Q3 2018

Nov 14, 2018
BUY
$351.14 - $408.51 $9.32 Million - $10.8 Million
26,550 Added 115.43%
49,550 $20 Million
Q2 2018

Aug 14, 2018
BUY
$284.6 - $344.99 $6.55 Million - $7.93 Million
23,000 New
23,000 $7.94 Million

Others Institutions Holding REGN

# of Institutions
1,487
Shares Held
85.7M
Call Options Held
1.53M
Put Options Held
1.43M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.5B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Friess Associates LLC Portfolio

Follow Friess Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Friess Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Friess Associates LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email